16004737 · Active · incorporated 1 year, 11 months ago · London
Biotech AI Biotech & Life Sciences Deep Tech Drug Discovery Series A
Ternary Therapeutics develops AI-designed molecular glue drugs for inflammatory diseases.
Ternarytx is a private limited company registered at Companies House under number 16004737, incorporated on 8 October 2024, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 22 filings for this company, including 3 funding rounds. Its most recent round closed in January 2026, raising £750k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Jan 2026 | £750k | £33.49 |
| Round 2 | Jun 2025 | £2.7m | £32.31 |
| Round 1 | Nov 2024 | £500k | £3.89 |
Showing the 13 most recent of 22 filings.
See the complete cap table with every shareholder, founder tags, dilution across 4 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.